Rats were survived for 7 (n¼5), 14 (n¼5) or 56 (n¼5) days. At euthanasia, necropsy was performed to assess for collateral damage and both kidneys underwent gross and histologic assessment.
INTRODUCTION AND OBJECTIVES: Cryoablation is a minimally invasive modality for the management of small renal cortical neoplasms. Successful ablation is dependent on achieving target temperatures (i.e. -20 C) that result in tumor cell death. However, in most cases no thermal sensing device is deployed to monitor the temperature. We investigated long-term oncological outcomes following cryoablation using Multi-Point Thermal Sensing (MTS) needles, which allow precise temperature determination at four points along the needle.
METHODS: We reviewed 20 cryoablation procedures for renal tumors < 4 cm done between 2005 to 2009; 11 procedures were performed with MTS needles with the goal of obtaining -20 C at the tumor margin, while 9 procedures were done without MTS needles. Patient demographics, tumor characteristics, and operative data were retrieved. Follow up CT or MRI imaging was used to assess recurrence status.
RESULTS: With a mean follow-up of 45 months, none of the 11 MTS patients experienced a recurrence, compared to 4 (44.4%) of the non-MTS patients (p ¼ 0.026). Of the biopsy-confirmed renal cancers, none of the 6 in the MTS group recurred compared to 3 of 6 in the non-MTS group (p ¼ 0.182). Age, gender, tumor size, tumor histopathology, grade, follow-up time, and skin-to-tumor distance were similar between the MTS and non-MTS groups. The MTS group had increased duration of freeze (p ¼ 0.041), increased procedure time (p ¼ 0.020), increased number of cryoprobes placed in order to achieve the targeted temperature (p ¼ 0.049), and a greater ratio of cryoprobes used per cm tumor (p ¼ 0.003).
CONCLUSIONS: Using MTS needles, precise target temperatures could be determined during cryoablation of renal tumors. The use of MTS needles was associated with improved oncological outcomes. . 197, No. 4S, Supplement, Tuesday, May 16, 2017 
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